Skip to main content
SpringerLink
Log in

Analgesic-induced chronic headache: long-term results of withdrawal therapy

  • Original Investigations
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

Headache characteristics are described in 139 patients with chronic daily or almost daily headaches due to regular intake of analgesics and the short- and long-term results of drug withdrawal. Drug-induced headache was described as dull, diffuse, and band-like, and usually started in the early morning. The mean duration of the original headache (migraine or tension headache) was 25 years; regular intake of drugs and chronic daily headache had started 10 and 6 years prior to withdrawal therapy, respectively. Patients took an average of 34.6 tablets or analgesic suppositories or antimigraine drugs per week containing 5.8 different substances. The drugs most often used were caffeine (95%), ergotalkaloids (89%), barbiturates (64%), and spasmolytics, paracetamol, and pyrazolone derivates (45%–46%). A total of 103 patients (68 migraine, 35 tension or combination headache) were available for interviews at a mean time interval of 2.9 years after an inpatient drug withdrawal programme. Chronic headache had disappeared or was reduced by more than 50% in two-thirds of the patients. Positive predictors for successful treatment were migraine as primary headache, chronic headache lasting less than 10 years, and regular intake of ergotamine. Drug intake was significantly reduced and patients used single substances more often. Patients who originally suffered from migraine, superimposed on the daily headache, also experienced a significant improvement in the frequency of the migraines and their intensity. Migraine prophylaxis through beta-blocking agents and calcium channel antagonists was more efficient after drug-withdrawal therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abbott PJ (1986) Caffeine: a toxicological overview. Med J Aust 145:518–521

    Google Scholar 

  2. Ala-Hurula V, Myllylä V, Hokkanen E (1982) Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations. Cephalalgia 2:189–195

    Google Scholar 

  3. Andersson PG (1975) Ergotamine headache. Headache 15:118–121

    Google Scholar 

  4. Bruyn GW (1985) Prevalence and incidence of migraine — a critical review. In: Carroll JD, Pfaffenrath V, Sjaastad O (eds) Migraine and beta-blockers. AB Hässle, Mölndal, pp 99–109

    Google Scholar 

  5. Dichgans J, Diener HC (1988) Clinical manifestations of excessive use of analgesic medication. In: Diener HC, Wilkinson M (eds) Drug induced headache. Springer, Berlin Heidelberg New York. pp 8–15

    Google Scholar 

  6. Dichgans J, Diener HC, Gerber WD, Verspohl EJ, Kukiolka H, Kluck M (1984) Analgetika-induzierter Dauerkopfschmerz. Dtsch Med Wochenschr 109:369–373

    Google Scholar 

  7. Diener HC, Bühler KU, Dichgans J, Geiselhart S, Gerber D, Scholz E (1988) Analgetikainduzierter Dauerkopfschmerz: Existiert eine kritische Dosis. Arzneimitteltherapie (in press)

  8. Diener HC, Gerber WD, Geiselhart D, Dichgans J, Scholz E (1988) Short and long term effects of withdrawal therapy in drug induced headache. In: Diener HC, Wilkinson M (eds) Drug induced headache. Springer, Berlin Heidelberg New York, pp 133–142

    Google Scholar 

  9. Dige-Petersen H, Lassen NA, Noer J, Toennesen KH, Olesen J (1977) Subclinical ergotism. Lancet II:55–65

    Google Scholar 

  10. Fogelholm R, Murros K (1985) Maproptiline in chronic tension headache: a double blind cross-over study. Headache 25:273–275

    Google Scholar 

  11. Henry P, Dartigues JF, Benetier MP, Lucas J, Duplan B, Jogeix M, Orgogozo JM (1985) Ergotamine- and analgesic-induced headaches. In: Clifford Rose F (ed) Migraine. Proc 5th Int Migraine Symp London 1984. Karger, Basel, pp 197–205

    Google Scholar 

  12. Hokkanen E, Waltimo O, Kallanrata T (1978) Toxic effects of ergotamine used for migraine. Headache 18:95–98

    Google Scholar 

  13. Horton BT, Peters GA (1963) Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 3:214–226

    Google Scholar 

  14. Isler H (1982) Migraine treatment as a cause of chronic migraine. In: Clifford Rose F (ed) Advances in migraine research and therapy. Raven Press, New York, pp 159–164

    Google Scholar 

  15. Kudrow L (1982) Paradoxical effects of frequent analgesic use. In: Critchley M, Fridman AP, Gorinin S, Sicuteri F (eds) Advances in neurology, vol 33. Raven Press, New York, pp 335–341

    Google Scholar 

  16. Kudrow L (1988) Possible mechanisms and treatment of analgesic induced chronic headache. In: Diener HC, Wilkinson M (eds) Drug induced headache. Springer, Berlin Heidelberg New York, pp 157–161

    Google Scholar 

  17. Lance JW, Curran DA (1964) Treatment of chronic tension headache. Lancet I:1236–1239

    Google Scholar 

  18. Lippman CW (1955) Characteristic headache resulting from prolonged use of ergot derivatives. J Nerv Ment Dis 121:270–273

    Google Scholar 

  19. Lucas RN, Falkowski W (1973) Ergotamine and methysergide abuse in patients with migraine. Br J Psychiatry 122:199–203

    Google Scholar 

  20. Manzoni GC, Micieli G, Granella F, Sandrini G, Zanferrari C, Nappi G (1988) Therapeutic approach to drug abuse in headache patients. In: Diener HC, Wilkinson M (eds) Drug induced headache. Springer, Berlin Heidelberg New York, pp 143–149

    Google Scholar 

  21. Mathew NT (1988) Management of ergotamine withdrawal. In: Diener HC, Wilkinson M (eds) Drug induced headache. Springer, Berlin Heidelberg New York, pp 150–156

    Google Scholar 

  22. Medina J, Diamond S (1977) Drug dependency in patients with chronic headaches. Headache 17:12–14

    Google Scholar 

  23. Mörland TJ, Storli OV, Mogstad TE (1979) Doxepine in the prophylactic treatment of mixed „vascular“ and tension headache. Headache 19:382–383

    Google Scholar 

  24. Peatfield RC, Fozard JR, Clifford Rose F (1986) Drug treatment of migraine. In: Vinken PJ, Bruyn GW, Klawans HL, Clifford Rose F (eds) Handbook of clinical neurology, vol 48, revised series 4. Elsevier, Amsterdam, pp 173–216

    Google Scholar 

  25. Pradalier A, Dry S, Baron JF (1984) Cephalée induite par l'abuse de tartrate d'ergotamine chez les migrainieux. Concours Med 106:106–110

    Google Scholar 

  26. Rapaport A, Weeks R, Sheftell F (1985) Analgesic rebound headache: theoretical and practical implications. In: Olesen J, Tfelt-Hansen P, Jensen K (eds) Proceedings of the Second International Headache Congress, Copenhagen. Stougaard Jensen, Copenhagen, pp 448–449

    Google Scholar 

  27. Rowsell AR, Neylan C, Wilkinson M (1973) Ergotamine induced headaches in migrainous patients. Headache 13:65–67

    Google Scholar 

  28. Saper JR, Jones JM (1986) Ergotamine tartrate dependency: features and possible mechanisms. Clin Neuropharmacol 9:244–256

    Google Scholar 

  29. Scholz E, Diener HC, Geiselhart S (1988) Drug induced headache — does a critical dosis exist? In: Diener HC, Wilkinson M (eds) Drug induced headache. Springer, Berlin Heidelberg New York, pp 29–43

    Google Scholar 

  30. Tfelt-Hansen P, Krabbe AE (1981) Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia 1:29–32

    Google Scholar 

  31. Vanecek J (1984) Antipyretic analgesics. In: Dukes MNG (ed) Meyler's side effects of drugs. Elsevier, Amsterdam, pp 135–150

    Google Scholar 

  32. Verspohl EJ (1986) Migränemittel. In: Ammon HTP (ed) Arzneimittelneben-und Wechselwirkungen, 2nd edn. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 318–328

    Google Scholar 

  33. Vrhovak B (1984) Anti-inflammatory analgesics and drugs used in gout. In: Dukes MNG (ed) Meyler's side effects of drugs, 10th edn. Elsevier, Amsterdam New York Oxford, pp 151–182

    Google Scholar 

  34. Wainscott G, Volans G, Wilkinson M (1974) Ergotamine induced headaches. Br Med J II:724

    Google Scholar 

  35. Wörz R (1983) Effects and risks of psychotropic and analgesic combinations. Am J Med 75:129–130

    Google Scholar 

  36. Wörz R, Baar H, Draf W, Garcia J, Gerbershagen HU, Gross D, Margin F, Ritter K, Scheifele J, Scholl W (1975) Kopfschmerz in Abhängigkeit von Analgetika-Mischpräparaten. Münch Med Wochenschr 117:457–462

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Tübingen, D-7400, Tübingen, Federal Republic of Germany

    H.-C. Diener, J. Dichgans, E. Scholz & S. Geiselhart

  2. Department of Neuropsychology, University of Tübingen, D-7400, Tübingen, Federal Republic of Germany

    A. Bille

  3. Department of Medical Psychology, University of Kiel, D-2300, Kiel, Federal Republic of Germany

    W.-D. Gerber

Authors
  1. H.-C. Diener
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Dichgans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Scholz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Geiselhart
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W.-D. Gerber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Bille
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diener, HC., Dichgans, J., Scholz, E. et al. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 236, 9–14 (1989). https://doi.org/10.1007/BF00314210

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314210

Key words

Search

Navigation